XBI icon

SPDR S&P Biotech ETF

193 hedge funds and large institutions have $3.95B invested in SPDR S&P Biotech ETF in 2015 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 68 reducing their positions, and 20 closing their positions.

Holders
193
Holders Change
+13
Holders Change %
+7.22%
% of All Funds
5.2%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.3%
New
34
Increased
52
Reduced
68
Closed
20
Calls
$689M
Puts
$2.06B
Net Calls
-$1.38B
Net Calls Change
-$920M
Name Market Value Shares Shares
Change
Shares
Change %
MC
201
Moors & Cabot
Massachusetts
-2,905 Closed
Franklin Resources
202
Franklin Resources
California
-2,800 Closed
MSU
203
Maple Securities USA
New Jersey
-2,193 Closed
PCM
204
Prelude Capital Management
New York
-2,100 Closed
CC
205
CQS Cayman
Cayman Islands
-2,100 Closed
WS
206
Wedbush Securities
California
-1,601 Closed
TRCT
207
Tower Research Capital (TRC)
New York
-1,234 Closed
BAS
208
Brown Advisory Securities
Maryland
-1,098 Closed
PPA
209
Parametric Portfolio Associates
Washington
-914 Closed
SHJ
210
Sharkey, Howes & Javer
Colorado
-700 Closed
PSI
211
Pinnacle Summer Investments
Virginia
-106 Closed
PA
212
Perceptive Advisors
New York
MIG
213
Mariner Investment Group
New York
SPM
214
Symmetry Peak Management
Pennsylvania
FANJ
215
Financial Architects (New Jersey)
New Jersey
PAMP
216
Polar Asset Management Partners
Ontario, Canada
CC
217
Caxton Corporation
New Jersey
ST
218
Sphinx Trading
Illinois
HCMT
219
Highland Capital Management (Texas)
Texas
BC
220
Broadfin Capital
New York
DCM
221
Driehaus Capital Management
Illinois
NCM
222
Nantahala Capital Management
Connecticut
TPCM
223
Tide Point Capital Management
Connecticut
OCM
224
Otter Creek Management
Florida
KCM
225
Kingdon Capital Management
New York